Similar observations show that insulin sensitizers may have beneficial effects on AD, and these benefits may be offset later by longer exposure to DM [30], [31], further supporting the idea that duration of diabetes may play an important role in AD pathogenesis. Here, INS is linked to Alzheimer disease.